Posted by ConfuzyQ on August 7, 2007, at 23:53:06
In reply to Maybe ditch Strattera.. » rjlockhart, posted by Jay_Bravest_Face on August 7, 2007, at 17:08:50
Amongst his Strattera discomfort did Matt mention feeling depressed in particular? Honestly don't recall but didn't think so. Otherwise, what's two months; maybe he shouldn't be discouraged. Has he ever reported feeling ok on anything yet? (Well stimulants yes, but those are apparently not feasible for him.)
> Like I said in my other post, (no, I am certainly
> not a anti-drug person or a $cientologist)...I just have encountered some things about Strattera that I have concerns...(not to be alarmist..but) here are a few:
> (These have turned a few heads too...as this one is referenced on psychcentral.)
> --------------------------------
> http://www.24-7pressrelease.com/view_press_release.php?rID=11216
>
> Press Release February 16, 2006
>
>
>
> Eli Lilly's Strattera - 130 reports of suicidality in one month
> A not released discussion paper from the British medical agency (MHRA) reveals 130 reports of suicidality in one month from treatment with Strattera. In addition the paper tells about 766 spontaneous reports of cardiac disorders and 172 of liver injury, and about 20 completed suicides.
>
>
>
> /24-7PressRelease/ - SWEDEN, February 16, 2006 - Strattera is a failed antidepressant, which Eli Lilly didn't succeed to get approved. It was recycled and used as an "ADHD medication", and marketed as the first "non stimulant medication for ADHD". As many parents, despite all published lies about the "benefits" of stimulants like Ritalin, Concerta and Adderall, don't want to give dangerous narcotic drugs to their kids, Lilly saw the chance to get a good market share for Strattera.
>
> But miracle drugs can fast turn into disasters - as proven through the whole psychiatric history.
>
> In April 2005 the European Agency for the Evaluation of Medicinal Products (EMEA) issued warnings that Strattera could give " hostility and emotional lability" in children and in September 2005 a Black Box Warning for suicide risk was issued for Strattera.
>
> When the truth about the actual risks was revealed, spontaneous reports also started to come in: In one month (23 September 2005 - 25 October 2005) 130 cases of suicidal and self-injurious behaviour were reported! This should be compared to the 301 cases reported in the period November 2002 - September 2005 - in 3 years. This means that 30 percent of all reports of suicidality were received in one month!
>
> This information is revealed in a not released discussion paper from 9 December 2005, written by the British MHRA and sent to the Swedish MPA. The information is gotten as a result of FOIA-requests, and released by court order.
>
> The main part of the information is classified - as suicide risk and other serious harmful effects of psychiatric drugs still are seen as "trade secrets" by the medical authorities. But the 130 new cases are now publicly known and can never be hidden again!
>
> In addition to the suicides and suicide attempts reported, the paper from the MHRA also tells about 766 spontaneous reports of cardiac disorders and 172 reports of liver injury.
> -------------------------
>
> Strattera gets 'black box' warning
>
> (I know most a.d.'s out there got this as well..but take with knowledge drug companies are out to protect their interests.)
>
> FDA Warns About ADHD Drug Strattera
>
> The Food and Drug Administration warned doctors Thursday about reports of suicidal thinking in some children and adolescents who are taking Strattera, a drug used to treat attention deficit hyperactivity disorder.
> Manufacturer Eli Lilly & Co. announced that a black-box warning will be added to the drug’s label in the United States. Such a warning is the most serious that can be added to a medication’s label, and similar warnings will be added to the drug’s labels in other countries. The company said a study showed instances of suicidal thinking were rare.
> In a statement, the FDA said it “is advising health care providers and caregivers that children and adolescents being treated with Strattera should be closely monitored for clinical worsening, as well as agitation, irritability, suicidal thinking or behaviors, and unusual changes in behavior, especially during the initial few months of therapy or when the dose is changed.”
> Eli Lilly said it provided the FDA results from Strattera clinical trials of 1,357 patients that found five youths taking the medication reported having suicidal thoughts, while none of 851 patients taking a placebo reported having any. One young person taking Strattera attempted suicide, but survived, company and FDA officials said.
> There was no evidence of increased suicidal thoughts in adults taking Strattera, which also goes by the generic name atomoxetine, the Indianapolis-based company said.
poster:ConfuzyQ
thread:774311
URL: http://www.dr-bob.org/babble/20070730/msgs/774691.html